Bloomberg: Regenerative medicine could be a $120 billion industry by 2030

Today Bloomberg reported about regenerative medicine in Japan. Four years ago, Shinya Yamanaka, a Kyoto University professor, had won the Nobel Prize for his work in stem cell biology, which has since sparked investment into regenerative medicine in Japan. Companies like Fujifilm and Hitachi Ltd. have also made investments on technology and products using Yamanaka’s discovery. Through an acquisition of  Japan Tissue Engineering Co. Ltd, Fujifilm is already supplying patients in Japan with artificially generated skin and cartilage. Read the full interview with FUJIFILM Corporation Mr. Toda, Executive Vice President, and Mr. Ban, General Manager of Regenerative Medicine business.
Read more.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.